Evolution of hematological and biochemical parameters in people living with HIV: a retrospective cohort study

Autores/as

  • Gilcelia Correia Santos Bernardes Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil https://orcid.org/0000-0002-2839-2443
  • Ana Paula Nogueira Godoi Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil https://orcid.org/0000-0002-9158-3218
  • Leilismara Sousa Nogueira Universidade Federal de Alfenas, Alfenas, (MG), Brazil https://orcid.org/0000-0002-8598-973X
  • Cristina Sanches Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil https://orcid.org/0000-0002-8562-1337
  • Melina Barros-Pinheiro Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil https://orcid.org/0000-0001-6895-3543

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2026.236851

Palabras clave:

HIV, Biochemical marker, Blood Cell Count, Hematologic tests

Resumen

Background: HIV remains a serious public health problem, affecting approximately 40,8 million people worldwide. Understanding the biochemical and hematological evolution of people living with HIV is essential for a better prognosis of infection. Similarly, it is important to evaluate whether sociodemographic data correlates with detectable viral load and the severity of the infection. Objective: to determine whether the hematological and biochemical parameters of people living with HIV change over time and to assess whether sociodemographic factors are associated with detectable viral load and disease severity. Method: This is a retrospective cohort study that followed the laboratory evolution after the diagnosis of patients treated at the Specialized Care Service (SCS) for a period of eight years. Results: Over the eight years of follow-up, a significant decline in glomerular filtration rate (GFR), changes in hematological parameters such as hemoglobin and mean corpuscular volume (MCV), as well as a progressive increase in hematological parameters, systemic inflammation response index (SIRI) and aggregate index of systemic inflammation (AISI), and a decline in the lymphocyte- monocyte ratio (LMR) were observed. In assessing sociodemographic data and detectable viral load, it was possible to identify an association between marital status and detectable viral load. Conclusions: Our results emphasize the importance of laboratory monitoring of people living with HIV to better understand the prognosis of infection. Also noteworthy is the need for new studies that evaluate the emerging hematological parameters in this population.

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

  • Gilcelia Correia Santos Bernardes, Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil

    MD

     

  • Ana Paula Nogueira Godoi, Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil

    MD

     

  • Leilismara Sousa Nogueira, Universidade Federal de Alfenas, Alfenas, (MG), Brazil

    PhD

     

  • Cristina Sanches, Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil

    PhD

     

  • Melina Barros-Pinheiro, Universidade Federal de São João del-Rei, Campus Centro-Oeste Dona Lindu, Divinópolis, (MG), Brazil

    PhD

     

Referencias

1. UNAIDS. Estatísticas - UNAIDS Brasil [Internet]. 2025 [citado 22 de outubro de 2025]. Disponível em: https://unaids.org.br/estatisticas/

2. Brasil. Brasil registra queda de óbitos por aids, mas doença ainda mata mais pessoas negras do que brancas [Internet]. Ministério da Saúde. 2015 [citado 12 de junho de 2024]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/noticias/2023/novembro/brasil-registra-queda-de-obitos-por-aids-mas-doenca-ainda-mata-mais-pessoas-negras-do-que-brancas

3. Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. The Lancet Global Health. março de 2015;3(3):e169–77.

4. NHI. Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring | NIH [Internet]. 2022 [citado 12 de junho de 2024]. Disponível em: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/plasma-hiv-1-rna-cd4-monitoring

5. Chandran A, Kanagasabapathy B, Ramesh C, Patil TR, Manikandan G, Palaniswamy A, et al. HIV-associated thrombocytopenia: Profiling hematological changes in the HIV infected and AIDS patients. Annals of Clinical and Laboratory Research. 2020;

6. Bernardes GCS, Godoi APN, Sales TLS, Nogueira LS, Barros-Pinheiro M, Sanches C, et al. Assessment of biochemical and hematological parameters related to aging in people living with HIV. Medicina (Ribeirão Preto) [Internet]. 28 de dezembro de 2024 [citado 14 de maio de 2025];57(4). Disponível em: https://www.revistas.usp.br/rmrp/article/view/214970

7. Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. abril de 2024;105(4):S117–314.

8. SBN. CKD-EPI – SBN [Internet]. 2024 [citado 12 de junho de 2024]. Disponível em: https://sbn.org.br/medicos/utilidades/calculadoras-nefrologicas/ckdepi/

9. Sociedade Brasileira de Diabetes. Diretriz da Sociedade Brasileira de Diabetes - Ed. 2023 [Internet]. Diretriz da Sociedade Brasileira de Diabetes - Ed. 2023. 2023 [citado 26 de junho de 2024]. Disponível em: https://diretriz.diabetes.org.br

10. Sociedade Brasileira de Cardiologia. Diretrizes - Sociedade Brasileira de Cardiologia [Internet]. 2021 [citado 26 de junho de 2024]. Disponível em: https://portal.cardiol.br/br/diretrizes

11. WHO - World Health Organization. HIV and AIDS — Fact sheet (15 July 2025) [Internet]. Geneva: World Health Organization; 2025 [citado 20 de outubro de 2025]. Disponível em: https://www.who.int/news-room/fact-sheets/detail/hiv-aids

12. De Waal R, Cohen K, Fox MP, Stinson K, Maartens G, Boulle A, et al. Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study. J Int AIDS Soc. 10 de abril de 2017;20(1):21317.

13. Jafari A, Khalili H, Dashti-Khavidaki S. Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention. Eur J Clin Pharmacol. setembro de 2014;70(9):1029–40.

14. Liu F, Xu A, Zhao H, Yang Z, Chen C, Ranieri B, et al. Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China. TCRM. abril de 2020;Volume 16:299–310.

15. Ferreira NDS, Dantas KE. Alterações hematológicas no paciente portador de HIV no momento do diagnóstico e seis meses após o início da terapia antiretroviral. Rev Med UFC. 13 de janeiro de 2021;61(1):1–7.

16. Wang D, Hou X, Yu X, Wang T, Ye Z, Li J, et al. Plasma hemoglobin and the risk of death in HIV/AIDS patients treated with antiretroviral therapy. Aging. 15 de maio de 2021;13(9):13061–72.

17 Ou-Yang H, Fu H-Y, Luo Y, Xu Z-Y, Liu J, Gao R, et al. Inflammation markers and the risk of hypertension in people living with HIV. Front Immunol. 2023;14:1133640. https://doi.org/10.3389/fimmu.2023.1133640.

18 Yu B, Jin Y, Huang S, Huang W. Evaluation value of SIRI combined with baseline indicators in immune reconstitution of PLWH after ART: A cohort study. Medicine. 2025;104:e43905. https://doi.org/10.1097/MD.0000000000043905.

19. Mu W, Patankar V, Kitchen S, Zhen A. Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection. Viruses. 2024;16:219. https://doi.org/10.3390/v16020219.

20. Lv T, Cao W, Li T. HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies. Journal of Immunology Research. 2021;2021:1–13. https://doi.org/10.1155/2021/7316456.

21. Zeng J, Zhang X, Jia L, Wu Y, Tian Y, Zhang Y. Pretreatment lymphocyte‐to‐ monocyte ratios predict AIDS‐related diffuse large B‐cell lymphoma overall survival. Journal of Medical Virology. 2021;93:3907–14. https://doi.org/10.1002/jmv.26655.

22. Ren H, Liu X, Wang L, Gao Y. Lymphocyte-to-Monocyte Ratio: A Novel Predictor of the Prognosis of Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. novembro de 2017;26(11):2595–602.

23. Okorie CN, Gutin SA, Getahun M, Lebu SA, Okiring J, Neilands TB, et al. Sex specific differences in HIV status disclosure and care engagement among people living with HIV in rural communities in Kenya and Uganda. Adetokunboh OO, organizador. PLOS Glob Public Health. 7 de abril de 2023;3(4):e0000556.

24. Aguiar RB, Leal MCC, Marques APDO, Torres KMS, Tavares MTDB. Idosos vivendo com HIV – comportamento e conhecimento sobre sexualidade: revisão integrativa. Ciênc saúde coletiva. fevereiro de 2020;25(2):575–84.

25. Castro SDS, Scatena LM, Miranzi A, Miranzi A, Nunes AA. Tendência temporal dos casos de HIV/aids no estado de Minas Gerais, 2007 a 2016*. Epidemiologia e Serviços de Saúde [Internet]. março de 2020 [citado 2 de agosto de 2024];29(1). Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2237-96222020000100307&lng=pt&nrm=iso&tlng=pt

26. Martins Rodrigues I, Martins Faria B, Verri Marquez L, Pires U da S, Ferreira Rende V, Silva WNT da, et al. Análise epidemiológica dos casos de Aids no Sudeste brasileiro de 2010 a 2019. Población y Salud en Mesoamérica. junho de 2022;19(2):162–83.

Descargas

Publicado

2026-11-18

Número

Sección

Artigo Original

Cómo citar

1.
Bernardes GCS, Godoi APN, Nogueira LS, Sanches C, Barros-Pinheiro M. Evolution of hematological and biochemical parameters in people living with HIV: a retrospective cohort study. Medicina (Ribeirão Preto) [Internet]. 18 de noviembre de 2026 [citado 18 de noviembre de 2026];59(1):e-236851. Disponible en: https://revistas.usp.br/rmrp/article/view/236851